Food and Drug Administration v. Alliance for Hippocratic Medicine
Pending petitionLinked with:
Docket No. |
Op. Below | Argument |
Opinion |
Vote |
Author |
Term |
23-235 |
5th Cir. |
TBD |
TBD |
TBD |
TBD |
TBD |
Issues: (1) Whether respondents have Article III standing to challenge the Food and Drug Administration’s 2016 and 2021 actions with respect to mifepristone’s approved conditions of use; (2) whether the FDA’s 2016 and 2021 actions were arbitrary and capricious; and (3) whether the district court properly granted preliminary relief.